That would be a game changer. But then, as we know from the GBM...

That would be a game changer. But then, as we know from the GBM trial, the "pinpoint" delivery is the other, current, obstacle.

Time will tell what "delivery-method" will in the end succeed. IV, IT, delivery via an OV or radioactive material or what else already exists, over time they will find a way to either re-activate a persons' immune system or lending it a helping hand.

And that again could make CHM a winner if CDH 17 and CLTX succeed as the " working mechanism " which just needs a better way to reach its target.

A lot of IFs and WHENs, until turned into a YES, will CHM still exist?

GLTA